BioWorld BioWorld MedTech BioWorld Asia BioWorld Science

BioWorld

Lilly’s retatrutide shows solid weight loss, reduced knee pain
Eli Lilly and Co.’s latest phase III results for the obesity and overweight populations suggest its triple agonist, retatrutide, can deliver significant weight loss that,...

More in BioWorld

BioWorld MedTech

Optimized organoid model gives insights into celiac disease
Investigators at the Netherlands Hubrecht Institute have developed a novel gut organoid model, and used it to gain insight into the functions on human microfold (M) cells....

More in BioWorld MedTech

BioWorld Science

Research unpicks molecular mechanism of vaccine-induced cardiac inflammation
The cardiomyositis that is a rare adverse effect of mRNA-based COVID vaccines is due to immune cell activity as a result of increased levels of the chemokines CXCL10 and...

More in BioWorld Science

BioWorld Asia

Immutep shares rocket on AU$528M deal with Dr. Reddy’s
Immutep Ltd.’s stock surged 31% on Tuesday morning following the news that it out-licensed rights to Dr. Reddy’s Laboratories Ltd. to develop and commercialize eftilagimod...

More in BioWorld Asia

BioWorld Insider podcast

The opioid crisis may not be front and center anymore, but it’s raging still. Elysium Therapeutics Inc. CEO Greg Sturmer talks about his firm’s candidate for a solution to the medical and societal problem.